Literature DB >> 8600371

Response of human keratinocytes to extremely low concentrations of N-methyl-N'-nitro-N-nitrosoguanidine.

H E Kleczkowska1, F R Althaus.   

Abstract

Since alkylating agents are widely present in the environment and constitute a continuous challenge to genome integrity, cells and organisms have developed defense mechanisms to remove such lesions. We monitored the response of human keratinocytes to a very low concentration of a methylating agent, namely 2.5 nM N-methyl-N'-nitro- N-nitrosoguanidine (MNNG). The effect of a 60-min exposure of quiescent cells to 2.5 nM MNNG was studied in terms of DNA integrity, poly(ADP-ribose) metabolism, clonogenic survival and DNA synthesis. We observed two waves of DNA strand break formation and resealing. Interestingly, the amount of DNA strand breaks in exposed cells was lower than in unexposed control cells. This phenomenon was also observed when cells were exposed to MNNG in the presence of a protein synthesis inhibitor, or when they were maintained on ice during the treatment. A dose of 2.5 nM MNNG stimulated poly(ADP-ribose) turnover, reduced the intracellular NAD+ content, stimulated DNA synthesis and caused a remarkable increase in clonogenic survival. Thus, the cellular responses to extremely low concentrations of MNNG differ sharply from those observed at higher doses of this carcinogen. We conclude that the very low dose response cannot be extrapolated from usual dose-response analyses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600371     DOI: 10.1016/0165-1218(95)00090-9

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  2 in total

1.  Poly ADP-ribosylation: a DNA break signal mechanism.

Authors:  F R Althaus; H E Kleczkowska; M Malanga; C R Müntener; J M Pleschke; M Ebner; B Auer
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

2.  Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine.

Authors:  Shoji Fukushima; Hideki Wanibuchi; Keiichirou Morimura; Min Wei; Dai Nakae; Yoichi Konishi; Hiroyuki Tsuda; Nobuaki Uehara; Katsumi Imaida; Tomoyuki Shirai; Masae Tatematsu; Tetsuya Tsukamoto; Masao Hirose; Fumio Furukawa; Keiji Wakabayashi; Yukari Totsuka
Journal:  Jpn J Cancer Res       Date:  2002-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.